Fluorescent creatinine assay
US6872573B2 · kind B2 · utility
4Cited by
13References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 2, 2003 |
| Grant date | Mar 29, 2005 |
| Priority date | — |
| Expiry date | Jan 12, 2023 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/206664
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A method of detecting creatinine in body fluids using an indicator which produces a fluorescent response when oxidized in the presence of a copperII/creatinine complex. A preferred indicator is 4-(1-methylhydrazino)-7-nitro benzooxadiazole (MNBDH).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.